Methicillin-resistant staphylococcus aureus (mrsa) drugs market to reach $3.25 billion by 2030 at 6.0% CAGR, driven by rising hospital acquired infections.
Read More
Methenamine hippurate tablets market to reach $14.49 billion by 2030 at 7.5% CAGR, driven by rising cases of urinary tract infections and rising healthcare expenditure.
Read More
The global nausea medicine market to reach $4.5 billion by 2030 at 6.9% cagr, driven by rising consumption of unhealthy diets.
Read More
Natural killer cell therapeutics market to reach $6.9 billion by 2030 at 11.9% cagr, driven by rising prevalence of cancer and demand for advanced immunotherapies.
Read More
Metastatic cancer drugs market to reach $79.32 billion by 2030 at 5.8% CAGR, driven by evolution of precision medicine and personalized therapies.
Read More
Natural immune booster market to reach $23.2 billion by 2030 at 8.4% cagr, driven by growing awareness of health and wellness and preventive healthcare trends.
Read More
Messenger ribonucleic acid quality monitoring market to reach $2.49 billion by 2030 at 11.0% CAGR, driven by increasing demand for personalized medicines.
Read More
Natural baby body massage oil market to reach $2.21 billion by 2030 at 7.3% cagr, driven by expanding e-commerce and rising demand for organic baby care products.
Read More
Nasal sprays market to reach $55.37 billion by 2030 at 10.4% cagr, driven by increasing prevalence of respiratory disorders and preference for localized treatments.
Read More
Messenger ribonucleic acid (mrna) synthesis raw materials market to reach $3.65 billion by 2030 at 4.0% CAGR, driven by growing incidence of cancer and chronic disorders.
Read More